What is the primary driver of Intuitive Surgical's revenue growth in this period?

The primary driver of Intuitive Surgical's revenue growth is the increased adoption and sales of its da Vinci Surgical Systems. This is evidenced by the 84% increase in unit sales and the successful launch of the new da Vinci S Surgical System, which accounted for 25 of the 35 systems sold.

How is the adoption of SFAS 123(R) impacting the company's financials?

The adoption of SFAS 123(R) on January 1, 2006, requires the company to recognize stock-based compensation expense. In the first quarter of 2006, this resulted in $5.1 million of non-cash stock compensation expense, which affected reported costs and operating expenses. While it reduces reported net income and EPS, it does not impact cash flow.

What is the significance of the growing recurring revenue stream?

The growing recurring revenue, which increased 72% to $34.9 million and now represents 45% of total revenue, is significant as it indicates a maturing business model. This stream from instruments, accessories, and services provides a more predictable and potentially higher-margin revenue source beyond the initial capital equipment sales, contributing to business stability and growth.

What is the company's financial health and liquidity position?

Intuitive Surgical is in a strong financial position with $221.5 million in cash, cash equivalents, and investments as of March 31, 2006. The company has no outstanding debt and generated $16.1 million in net cash from operating activities during the quarter, indicating healthy liquidity and the ability to fund future operations and growth initiatives.

ISRG 10-Q Quarterly Report Q1 FY2006 — Revenue, Net Income, EPS

Summary

Intuitive Surgical Inc. (ISRG) demonstrated robust financial performance in the first quarter of 2006, with total revenue soaring by 86% to $77.3 million compared to the prior year period. This impressive growth was primarily driven by a significant increase in sales of its da Vinci Surgical Systems, with unit sales up 84% to 35 systems, including 25 of the newly launched da Vinci S Surgical System. Recurring revenue from instruments, accessories, and services also saw strong growth, increasing by 72% and representing 45% of total revenue, indicating a maturing business model with increasing revenue streams beyond capital equipment sales. Profitability metrics showed substantial improvement, with operating income growing by 144% to $21.7 million. The company also saw an improvement in gross profit margin to 66.9%. A notable change impacting reported expenses is the adoption of SFAS 123(R) on January 1, 2006, which requires the recognition of stock-based compensation expense. This resulted in $5.1 million of stock compensation expense for the quarter, impacting cost of revenue and operating expenses but notably, it is a non-cash charge. The company ended the quarter with a strong balance sheet, including $221.5 million in cash, cash equivalents, and investments, and no outstanding debt, positioning it well for continued growth.

Key Highlights

1Total revenue surged 86% year-over-year to $77.3 million, driven by strong product and service sales.
2Unit sales of da Vinci Surgical Systems increased 84% to 35 units, including 25 of the new da Vinci S model, highlighting successful new product introduction.
3Recurring revenue (instruments, accessories, services) grew 72% to $34.9 million, now comprising 45% of total revenue, indicating a growing service and consumables business.
4Operating income saw a significant increase of 144% to $21.7 million, reflecting improved operational leverage.
5Gross profit margin improved to 66.9% from 65.6% in the prior year quarter.
6The company adopted SFAS 123(R), resulting in $5.1 million of stock-based compensation expense in the quarter, a non-cash charge impacting reported earnings.
7A robust cash position of $221.5 million in cash, cash equivalents, and investments with no debt provides strong financial flexibility.

INTUITIVE SURGICAL INC Quarterly Report for Q1 Ended Mar 31, 2006

Summary

Key Highlights

Frequently Asked Questions